Advertisement
Advertisement
CRSP
CRISPR Therapeutics AG
50.07
USDSponsored
+1.51
+3.11%
Nov 06, 15:59 UTC -5
Closed
After-Market
49.77
-0.30
-0.59%
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG Financial Snapshot
| Market Cap | 4.83B |
| Beta | 1.92 |
| Earnings Per Share (EPS) | -4.74 |
| Price-to-Book (P/B) Ratio | 2.76 |
| Operating Margin | -1812.07% |
| Total Debt/Equity (D/E) | 33.56% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -24.96% |
| Current Ratio | 17.85% |
| Free Cash Flow | -193.55M |
